News

Fischer Medical Ventures Limited, formerly Fischer Chemic Limited, announced the appointment of David Yeow as an additional independent director with effect from September 3, 2026, for a term of five years, subject to shareholder approval. The company also reconstituted its audit committee following Yeow’s appointment, and will hold its 33rd Annual General Meeting on September 29, 2026, via video conferencing, while the company’s share transfer books will be closed from September 23, 2026, to September 29, 2026.

Fischer Medical Ventures Limited, formerly Fischer Chemic Limited, informed the BSE Limited and National Stock Exchange of India Ltd. that the register of members and share transfer books will remain closed from September 23, 2026, to September 29, 2026, for the Annual General Meeting scheduled on September 29, 2026, with a record date of September 22, 2026, to determine dividend and voting rights, and a cut-off date of September 4, 2026, for dispatch of the Annual General Meeting notice.

Fischer Medical Ventures Limited announced that its Board of Directors approved the allotment of 4,54,210 equity shares with a face value of Re. 1 each at an issue price of Rs 23.40 per share, including a premium of Rs 22.40, to FMV Holdings Pte Ltd, a promoter entity, upon the exercise of warrants. The company received Rs 79,71,385.50 in consideration for the allotment.

Fischer Medical Ventures Limited announced that its board approved the allotment of 1,42,78,217 equity shares with a face value of Re. 1 each at an issue price of Rs 23.40 per share, including a premium of Rs 22.40, following the conversion of warrants. The company received Rs 25,05,82,708.35 in consideration for the allotment, with Mr. Shankar Varadharajan, FMV Holdings Pte Ltd, and Vikasa India Eif I Fund being the allottees.

Fischer Medical Ventures Limited announced that its Board of Directors approved the allotment of 23,00,000 equity shares with a face value of Re. 1 each at an issue price of Rs 23.40 per share, including a premium of Rs 22.40, to Mr. Shankar Varadharajan, a promoter, upon the exercise of convertible warrants, resulting in a total consideration received of Rs 4,03,65,000.